RE: Target price30 Nov 2021 13:30
IMO we will dispense with the tests and open up everything again....and much sooner than you think. This is when the variant is confirmed as not a concern, although highly transmissible, only causes mild symptoms. Therefore, no justification to have these restrictions and we are ok not to test as intensive as we are now.
So, the uptick in tests will be very short-term, nothing to get excited about, and the SP settling around the 2.7-3p mark is justified re market cap. Shouldn't be rated higher than this based on fundamentals.
DYOR